Regenerex Pharma (RGPX) Gross Margin (2014 - 2020)
Regenerex Pharma (RGPX) reported Gross Margin of 101.1% for Q4 2020, down 18950.0% year-over-year from N/an in Q1 2020, and down 241.08% quarter-over-quarter from 71.67% in Q3 2020.
Regenerex Pharma (RGPX) Gross Margin (2014 - 2020) Analysis & Trends
Regenerex Pharma (RGPX) has 3 years of Gross Margin data on file, last reported at 101.1% in Q4 2020.
- Gross Margin for Q4 2020 came in at 101.1%, down 18950.0% year-over-year; the trailing twelve-month figure through Dec 2020 was 46.31% (changed N/A YoY), and the FY2020 annual result was 34.36%, changed N/A from the prior year.
- Gross Margin fell to 101.1% in Q4 2020 per RGPX's latest filing, from 71.67% in the prior quarter.
- Over five years, Gross Margin peaked at 89.61% in Q2 2020 and troughed at 101.1% in Q4 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -101.10% |
| Sep 30, 2020 | 71.67% |
| Jun 30, 2020 | 89.61% |
| Mar 31, 2020 | -62.01% |
| Dec 31, 2019 | 88.39% |
| Aug 31, 2014 | 79.34% |